IDRx

Id Rx

Biotechnology, 215 1st St Ste 200, Cambridge, Massachusetts, 02142, United States, 11-50 Employees

idrx.com

  • LinkedIn

phone no Phone Number: +16*********

Who is IDRX

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combinatio...

Read More

map
  • 215 1st St Ste 200, Cambridge, Massachusetts, 02142, United States Headquarters: 215 1st St Ste 200, Cambridge, Massachusetts, 02142, United States
  • 2022 Date Founded: 2022
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 446110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from IDRX

IDRx Org Chart and Mapping

Employees

Debbie Johnson

Vice President Clinical Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding IDRx

Answer: IDRx's headquarters are located at 215 1st St Ste 200, Cambridge, Massachusetts, 02142, United States

Answer: IDRx's phone number is +16*********

Answer: IDRx's official website is https://idrx.com

Answer: IDRx's revenue is $10 Million to $25 Million

Answer: IDRx's SIC: 2834

Answer: IDRx's NAICS: 446110

Answer: IDRx has 11-50 employees

Answer: IDRx is in Biotechnology

Answer: IDRx contact info: Phone number: +16********* Website: https://idrx.com

Answer: IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combination regimens in cancer and the successful drug cocktails purposely engineered in other disease areas such as cystic fibrosis and antivirals, IDRx aims to address the limitations of todays precision cancer medicines with highly -selective, purposely -designed drug combinations to help more patients achieve prolonged, durable responses to therapy earlier in the course of their disease. Founded in 2022, IDRxs leadership team has extensive experience in drug development, and collectively has been involved in the discovery, development and commercialization of more than 10 approved drugs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access